Factors associated with endometrial cancer and hyperplasia among middle-aged and older Hispanics.

Gynecologic Oncology
Ana M RodriguezYong-Fang Kuo

Abstract

While disparities in endometrial hyperplasia and endometrial cancer are well documented in Blacks and Whites, limited information exists for Hispanics. The objective is to describe the patient characteristics associated with endometrial hyperplasia symptoms, endometrial hyperplasia with atypia and endometrial cancer, and assess factors contributing to racial/ethnic differences in disease outcomes. This single-center, retrospective study included women aged ≥50 years with ≥ two encounters for endometrial hyperplasia symptoms, endometrial hyperplasia with atypia and endometrial cancer between 2012 and 2016. Multivariate logistic regression models evaluated the predictors of endometrial cancer and hyperplasia. We included 19,865 women (4749 endometrial hyperplasia symptoms, 71 endometrial hyperplasias with atypia, 201 endometrial cancers) with mean age of 60.45 years (SD 9.94). The odds of endometrial hyperplasia symptoms were higher in non-Hispanic Blacks (Odds Ratio [OR] 1.56, 95% Confidence Interval [CI] 1.20-1.72), Hispanics (OR 1.35, 95% CI 1.22-1.49), family history of female cancer (OR 1.25, 95% CI 1.12-1.39), hypertension (OR 1.24, 95% CI 1.14-1.35), and birth control use (OR 1.29, 95% CI 1.15-1.43). Odds of endometrial ca...Continue Reading

References

Nov 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas C Randall, Katrina Armstrong
Nov 9, 2006·American Journal of Epidemiology·Veronica Wendy SetiawanBrian E Henderson
May 27, 2008·The American Journal of Medicine·Bo ZhouBin Wang
Dec 17, 2008·Cancer Control : Journal of the Moffitt Cancer Center·Larissa A MeyerKaren H Lu
Apr 28, 2009·American Journal of Obstetrics and Gynecology·Susan D ReedNoel S Weiss
Mar 20, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Sara H OlsonElena B Elkin
Sep 19, 2012·CA: a Cancer Journal for Clinicians·Vilma E CokkinidesAhmedin Jemal
Oct 31, 2012·Cancer Causes & Control : CCC·Linda S CookCharles L Wiggins
Dec 15, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Patricia M JamisonBrenda K Edwards
May 4, 2013·Endocrine·Katherine EspositoDario Giugliano
Aug 21, 2013·Obstetrics and Gynecology International·Jae H KangShelley S Tworoger
Feb 4, 2014·Cancer Causes & Control : CCC·Ashley S FelixLouise A Brinton
Dec 3, 2014·Gynecologic Oncology·Ana M RodriguezYong-Fang Kuo
Jan 15, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Britton TrabertLouise A Brinton
Mar 24, 2015·Geburtshilfe und Frauenheilkunde·G EmonsUNKNOWN Uterus commission of the Gynecological Oncology Working Group (AGO)
Dec 17, 2015·Journal of Cancer Research and Clinical Oncology·Ana M RodriguezYong-Fang Kuo
Feb 3, 2016·Cancer Causes & Control : CCC·Oluwole A BabatundeJames R Hebert
Sep 6, 2018·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ashley S Felix, Louise A Brinton
Nov 6, 2018·International Journal of Cancer. Journal International Du Cancer·Olivia RaglanMaria Kyrgiou
Feb 26, 2019·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Antonio TravaglinoFulvio Zullo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Obstetrical & Gynecological Survey
Ben E MontgomeryC.J. Dunton
Journal of the Formosan Medical Association = Taiwan Yi Zhi
Yu-Li ChenChi-An Chen
© 2021 Meta ULC. All rights reserved